• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Systematic Review Protocol for Leicester Diabetes Risk Scores

by
November 8, 2026
in Health
Reading Time: 7 mins read
0
Systematic Review Protocol for Leicester Diabetes Risk Scores

Systematic Review Protocol for Leicester Diabetes Risk Scores

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers have published a protocol for a systematic review designed to evaluate the performance of two widely used clinical prediction models for identifying undiagnosed type 2 diabetes and prediabetes. The study, registered with PROSPERO under the identifier CRD420251005841, focuses specifically on the Leicester Risk Assessment score (LRA) and the Leicester Practice Risk score (LPR). These diagnostic tools are currently employed in community and primary care settings to estimate an individual’s risk of having undiagnosed type 2 diabetes mellitus or non-diabetic hyperglycaemia. The review aims to bring together all external validations of these models to assess their accuracy across diverse populations and care pathways.

The background for this review is rooted in the significant public health burden of undiagnosed diabetes in the United Kingdom. Approximately one million adults in the UK are estimated to have undiagnosed type 2 diabetes, while a further 5.1 million adults suffer from non-diabetic hyperglycaemia, a condition characterized by raised blood glucose levels that do not yet meet the threshold for a diabetes diagnosis. Left untreated, type 2 diabetes can lead to serious complications, with reported life expectancy up to ten years less than individuals without the condition. Additionally, the condition places a substantial economic strain on the health system, with approximately 10% of annual National Health Service expenditure attributed to type 2 diabetes management.

The Leicester Risk Assessment score was developed over a period of 15 years using a diagnostic prediction model to identify prevalent undiagnosed type 2 diabetes and non-diabetic hyperglycaemia. Originally structured as a ‘tick box’ questionnaire, the LRA generates a numerical score based on several predictors, including age, sex, ethnicity, first-degree family history of type 2 diabetes, waist circumference, body mass index, and the use of antihypertensive medication or the presence of hypertension. The model is recommended by the National Institute for Health and Care Excellence as part of a two-stage strategy to identify adults at high risk of developing type 2 diabetes, facilitating targeted interventions such as the NHS Diabetes Prevention Programme.

The Leicester Practice Risk score is a variant of the LRA specifically designed for use within primary care settings. While similar in structure, the LPR excludes waist circumference as a predictor because this measurement is often poorly recorded in primary care electronic records. Although both models were developed as diagnostic tools to identify individuals who currently have undiagnosed conditions, they have subsequently been used as prognostic models to identify individuals who may go on to develop type 2 diabetes in the future. This dual usage highlights a critical distinction between diagnostic models, which estimate the probability of a condition currently being present, and prognostic models, which estimate the risk of developing a health outcome over a specified time period.

The primary aim of the systematic review is to assess the performance of the LRA and LPR in terms of discrimination, calibration, and clinical utility. The researchers plan to summarize available data in a meta-analysis to evaluate how well these models predict an individual’s risk of undiagnosed type 2 diabetes and non-diabetic hyperglycaemia. A key objective is to assess the effect of any additional predictor variables that may have been added to either model in subsequent studies. The review will also examine the strength of association for existing predictor variables and evaluate the models’ performance in predicting both prevalent and future disease.

The methodology for this review involves a comprehensive citation search strategy rather than a traditional database search. The team will search Scopus, Web of Science, and Google Scholar, restricted to full-text papers in English. By using a forwards citation search focused on the original model development papers and three subsequent validations, the researchers aim to identify all studies that have implemented, modified, or validated the LRA and LPR since August 2010. This approach is expected to be highly effective, with previous comparisons suggesting that such citation strategies can identify up to 99.7% of total citations found by traditional database searches.

Data extraction will be conducted independently by two reviewers using a form based on the Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies checklist. The extraction process will capture detailed study information, including the source of data, study design characteristics, and patient demographics such as mean age, percentage of males, family history of diabetes, and ethnicity. The team will also extract specific model performance measures, including calibration slope, intercepts, goodness-of-fit tests, and the c-statistic, which is identical to the area under the receiver operating curve. These metrics are essential for determining how well the models distinguish between individuals with and without the target condition.

To handle missing information, the researchers will employ methods outlined by Debray et al. to estimate performance measures and confidence intervals where they are not explicitly stated in the original publications. If five or more studies are available with sufficient data, a random-effects meta-analysis will be performed to account for heterogeneity between studies. The analysis will calculate between-study variance and the percentage of total variation due to heterogeneity, providing a robust summary of model performance. Subgroup and sensitivity analyses will be used to explore potential sources of heterogeneity, such as differences in country, diagnostic criteria, or the specific method used to validate the model.

The review will also assess the risk of bias in included studies using the Prediction study of Risk of Bias Assessment Tool. This tool evaluates participants, predictors, outcome, and analysis domains to rate studies as having low, high, or unclear risk of bias. Additionally, the team will evaluate reporting deficiencies, noting that calibration and discrimination measures are often poorly reported or omitted in prediction model studies. Funnel plots will be used to visually assess for any evidence of publication bias, ensuring that the final conclusions are based on a comprehensive and unbiased body of evidence.

One significant limitation of the original LRA model is that the model intercept was not published in the original paper, although the authors have provided it upon request. This omission means that some validations may have essentially recalibrated the model by estimating the intercept, which could affect the interpretation of performance measures. The review will specifically consider whether the full model was validated or if the intercept was estimated, as this distinction is crucial for understanding the model’s applicability in new populations. The findings will ultimately inform the potential update and recalibration of these models, aiming to improve outcomes through earlier diagnosis and management of undiagnosed type 2 diabetes and prediabetes.

The review protocol specifies that eligible studies must be full-text publications in English, while abstracts alone are excluded because they typically lack sufficient detail to describe the target population or assess study quality. The researchers will not restrict the target population, allowing for a comprehensive assessment of model performance across all settings. Studies involving participants who already have a diagnosis of type 2 diabetes or non-diabetic hyperglycaemia will be excluded from the analysis. This inclusion strategy ensures that the review focuses specifically on the models’ ability to identify undiagnosed conditions in individuals who have not yet been clinically classified as having the disease.

The search strategy relies on a forwards citation approach, identifying key publications as seed references to maximize the likelihood of finding all relevant papers. The team will use Scopus, Web of Science, and Google Scholar to identify citations from these key references. Additionally, a keyword search in the PubMed database will be conducted using descriptors extracted from the retrieved articles to ensure the search is as comprehensive as possible. Reference and citation lists of the retrieved articles will also be hand-searched for further papers of interest. This multi-database approach is designed to capture the broad range of studies that have applied these specific models since their initial development.

Data management will be handled using Covidence systematic review software for screening and Zotero for managing selected articles and PDF files. Two reviewers will independently screen titles and abstracts for eligibility, followed by a full-text assessment. Any disagreements between reviewers will be resolved through discussion, with a third reviewer involved if consensus cannot be reached. The study selection process will be documented in a flow chart in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. This rigorous selection process is intended to minimize selection bias and ensure that the included studies accurately reflect the available evidence on model performance.

The data extraction form will capture detailed information on the statistical methods used, including how any new predictors were included and how missing data was handled. The team will also extract any clinical utility or cost-effectiveness measures reported in the studies, such as net benefit, decision curve analysis, or incremental cost-effectiveness ratios. For studies where performance measures are not explicitly stated, the researchers will use methods outlined by Debray et al. to estimate these values. This includes calculating missing total observed-to-expected ratios and standard errors using statistical equations based on the total number of observed and expected events and the total sample size. Calibration-in-the-large will also be estimated using the linear predictor and regression coefficients of the model.

The review will perform all analyses separately for the Leicester Risk Assessment score and the Leicester Practice Risk score to ensure each model is evaluated individually. Because these are diagnostic models, they can be evaluated using methods described for the meta-analysis of diagnostic test accuracy, which utilizes a Bayesian approach. This approach allows for more complex analyses that consider multiple thresholds for risk grouping and fits a random-effects model for sensitivity and specificity. The c-statistics will be transformed using a logit transformation to facilitate meta-analysis. If more than five studies are sufficiently similar, a random-effects meta-analysis of calibration and discrimination will be performed, with between-study variance and the percentage of total variation due to heterogeneity calculated to provide a robust summary of model performance.

Subgroup analyses will be used to investigate potential sources of heterogeneity, comparing model performance in the whole study population with that in subgroups defined by country, the method or criteria used to diagnose diabetes, and whether the validation was based on the score or the model. Meta-regression will be used to evaluate model performance if the number of identified studies supports this. The researchers acknowledge that using aggregate data for meta-regression can lead to ecological bias, so characteristics in the target populations will be summarized and explored in subgroup analyses unless individual patient-level data is available. This careful handling of heterogeneity is crucial for interpreting the results in the context of diverse populations and care pathways.

The protocol notes that the original paper for the Leicester Risk Assessment score did not report the full model, specifically omitting the intercept, although the corresponding author provides this on request. Validations that estimate the model intercept could be considered a form of recalibration, which must be considered when evaluating reported performance measures. The review will specifically assess whether the full model was validated or if the intercept was estimated, as this distinction is important for understanding the model’s applicability in new populations. The LRA has been used as both a diagnostic and prognostic tool, despite being developed as a diagnostic model using a cross-sectional dataset, which may result in separate analyses to evaluate differing model performance when predicting prevalent and incident type 2 diabetes.

Subject of Research: Systematic review protocol for Leicester diabetes risk prediction models

Article Title: Performance of the Leicester risk assessment and Leicester practice risk scores for assessing the risk of undiagnosed type 2 diabetes or prediabetes in diverse populations: protocol for a systematic review of published validations and updates

Article References: Haddon, L., Ensor, J., Khunti, K., & Gray, L. J. (2026). Performance of the Leicester risk assessment and Leicester practice risk scores for assessing the risk of undiagnosed type 2 diabetes or prediabetes in diverse populations: protocol for a systematic review of published validations and updates. Diagnostic and Prognostic Research, 10(1), Article 2. https://doi.org/10.1186/s41512-026-00219-w

Image Credits: AI Generated

DOI: 10.1186/s41512-026-00219-w

Keywords: type 2 diabetes, risk prediction models, systematic review, Leicester Risk Assessment, clinical prediction, undiagnosed diabetes, primary care, diagnostic accuracy, Performance, Leicester, risk, assessment

News Source: Ophelia Keating. (November 8, 2026). Systematic Review Protocol for Leicester Diabetes Risk Scores. Scienmag.

Tags: assessmentclinical predictiondiagnostic accuracyLeicesterLeicester Risk Assessmentperformanceprimary careriskrisk prediction modelssystematic reviewType 2 diabetesundiagnosed diabetes
Share12Tweet7Share2ShareShareShare1

Related Posts

Emergency Department Boarding Times Vary Fortyfold Across Brazilian Public Hospitals

Emergency Department Boarding Times Vary Fortyfold Across Brazilian Public Hospitals

November 18, 2026
Occupational Therapy Fieldwork Setting Links Lack Robustness in Kuwait

Occupational Therapy Fieldwork Setting Links Lack Robustness in Kuwait

November 18, 2026

Dual Parasite Exposure Identified in Three Percent of Northern Iran Pregnant Women

November 18, 2026

Extracellular Vesicles Link Systemic Comorbidities to Vascular Dysfunction in Atherogenesis

November 18, 2026

POPULAR NEWS

  • Coal Gangue Aggregates Can Replace Natural Stone in Concrete Applications

    Coal Gangue Aggregates Can Replace Natural Stone in Concrete Applications

    29 shares
    Share 12 Tweet 7
  • Cluster-Based Training Selection Outperforms Active Learning for Material Property Prediction

    29 shares
    Share 12 Tweet 7
  • Cesarean Section Rates Reached Forty Percent Among Surveyed Mothers in Njombe Region

    29 shares
    Share 12 Tweet 7
  • Testosterone Injections Exacerbate Pre-Neoplastic Prostate Lesions in NKX3.1-Deficient Mice

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Emergency Department Boarding Times Vary Fortyfold Across Brazilian Public Hospitals

Mycologists Identify Three New Wood-Inhabiting Fungal Species in Northeast China

Metabarcoding Survey in Southern Crete Reveals Hundreds of Candidate Insect Records

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.